Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
about
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyThe association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysisGenetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination SurveyLack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studiesInactivating mutations in NPC1L1 and protection from coronary heart diseaseParaoxonase 1 (PON1) gene variants are not associated with clopidogrel response.Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases.Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies.The Trp719Arg polymorphism of the KIF6 gene and coronary heart disease risk: systematic review and meta-analysis.ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study.Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians.Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls.
P2860
Q24615705-19578914-998B-4AF3-8ECB-74387A1C833FQ24801635-7637702A-9E18-4EE7-9A3E-E394937E99E5Q28395880-F0F540FF-45E2-40D8-9DD1-97F453B2A29EQ30499949-FAE256A1-C68C-4C20-A161-4FC2801A1626Q35105445-3BFE9C12-873F-4371-AC66-7CFA66E6BCD3Q35648335-4C1B497E-9543-44B1-9362-40F7E9845856Q36019900-1118C14B-5F4A-4D36-BBD2-CA81C93F2D65Q37111272-2C1F9852-642E-4D6D-97BF-B025C92594B0Q38784846-0CF80BB9-E246-47A3-9B09-6B61C1EFA162Q38924697-9E56CEF4-EF2E-4D66-877E-91D3508EADDCQ39012112-6CF7D58F-350B-4D0C-8EA5-BD3C6450E7B0Q39092864-39044998-00BD-4CAB-A8E5-3F8C1B46FF98Q40254292-B6BD38F2-7D81-4741-B718-7F42E25B859FQ43235426-1EF0E097-F4BD-4AF7-863A-11A8417DD9A5Q44040200-4DAA8C8D-9FD1-49DA-A222-8F3DE475A646Q50164148-7733EC09-A996-4197-B235-2EDC5EFBE011
P2860
Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Paraoxonase1-192 polymorphism ...... ssociated with decreased HDLs.
@ast
Paraoxonase1-192 polymorphism ...... ssociated with decreased HDLs.
@en
type
label
Paraoxonase1-192 polymorphism ...... ssociated with decreased HDLs.
@ast
Paraoxonase1-192 polymorphism ...... ssociated with decreased HDLs.
@en
prefLabel
Paraoxonase1-192 polymorphism ...... ssociated with decreased HDLs.
@ast
Paraoxonase1-192 polymorphism ...... ssociated with decreased HDLs.
@en
P2093
P356
P1476
Paraoxonase1-192 polymorphism ...... ssociated with decreased HDLs.
@en
P2093
P304
P356
10.1161/01.ATV.21.3.415
P407
P577
2001-03-01T00:00:00Z